
Interventional/Structural Cardiologist @DoylestownHlth, former @yalecardiology structural fellow, @hopkinsheart IC fellow, @TJheartfellows. Tweets are my own.
Doylestown, PA
Joined December 2017
- Tweets202
- Following165
- Followers396
- Likes905
Our 1000th TAVR! So proud of our amazing team!! @DoylestownHlth
1
49
3,837
When you’re one of the few, 2.2% hits differently
As a woman performing TAVR & M-TEER in community practice, this resonates deeply
Grateful for our team @DoylestownHlth
May these statistics become history for the next generation!
doi.org/10.1016/j.jscai.2026…
#WIC #StructuralHeart
Thrilled to welcome the Pascal platform to our structural heart program @DoylestownHlth @PennMedicine Expanding our toolkit means more options, more precision & more patients getting the care they deserve. Proud of the excellent outcomes we continue to achieve with every M-TEER🫀
1
183
Hospital-level variability in NSTEMI management and outcomes @CRT_meeting #CRT2026
2
123
HAPPY #HOLI !!
May God paint the canvas of your life with colors of LOVE, LAUGHTER, HAPPINESS, PROSPERITY, GOOD HEALTH and SUCCESS this year!! ❤️
2
160
THE FIRST TEAM TO LIFT THE T20 WORLD CUP UNBEATEN 🏆 #11YEARS
2
188
Another proud sister moment! ❤️
@nirmehta
linkedin.com/mwlite/feed/pos…
1
90
A practical guide for peri-procedural antithrombotic management across cardiology @JACCJournals
jacc.org/doi/epdf/10.1016/j.…
6
240
Negative studies are just as important as ➕. Key to not let our desire for a➕ result change how we interpret results. This leads to ⬆️ costs w/o pt benefit, inappropriate media coverage & pt confusion! #CardioTwitter has huge influence-we have to be responsible #patientoutcomes – at Pennsylvania, USA
Are we changing how we interpret results! or are we ignoring the lack of statistical significance & using numerically better as "evidence" for IV ferric... administration being better?! published in @TheLancet
thelancet.com/journals/lance… @IronmanKalra @AHAMeetings
1
1
No diff in outcomes w/ immediate VA-ECMO vs early conservative strategy in SCAI D-E CS. Though no diff in complications,
1.40% pts in conservative arm needing ECMO eventually.
2.Only 13/58 pts w/ LV venting w/ IABP/Impella in immediate VA-ECMO group. doi.org/10.1161/CIRCULATIONA… – at Pennsylvania, USA
Tricuspid TEER in symptomatic severe TR patients—consistent symptom improvement, high safety signals, durability likely good, TEE imaging of TV may be a technical limitation (high SLDA rate) and ICE skills may be needed. Most importantly, prospective RCTs are needed #TCT2022
EXPAND G4–subjects in all groups had clinically significant MR reduction, improved functional capacity, and quality of life, and low 30-day adverse event rates, including mortality rates less than 2% #TCT2022 #JasonHRogers
The benefit of 4 clip sizes w/ G4 system—“There can be a patient-clip mismatch where you could pick the wrong clip size—in general 80-90% of the time the first clip choice will be either NTW or XTW depending on leaflet length” #TCT2022 #GaganDSingh #TEER #MitraClip
1
Commissural alignment impacts coronary access, THV hemodynamics, and the feasibility of redo-TAVR. This state of the art review aims to present an in-depth insight of commissural alignment in TAVR #TCT2022 jacc.org/doi/10.1016/j.jcin.… – at Boston, MA
Still one of my favorite parts about in-person conferences—catching up with old friends and making new ones! 💗#TCT2022 @Vratika_Agarwal @glorifiedplummr @johnkforrest @SteffneK @CynthiaPhilip19 @YaleCardiology @Yalecards @TCTMD @TCTConference @crfheart
13
STS/TVT registry analysis for role for TEER in cardiogenic shock—lower rate of hospitalization and mortality in successful TEER #TCT2022 @adnanalkhouli @TCTConference @TCTMD @crfheart – at Boston, MA
The very awaited PROTECTED TAVR—will your practice change based on this? #TCT2022 @crfshj @TCTConference @TCTMD @crfheart
Knowing strengths and weaknesses of each valve platform is crucial as a TAVR operator—which valve platform is the right one for your patient is dependent on a lot of different factors! #TCT2022 @Medtronic @anvoramd #HemalGada #Boston @crfshj @TCTConference @crfheart






































